188 related articles for article (PubMed ID: 11375740)
1. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery.
Masimirembwa CM; Thompson R; Andersson TB
Comb Chem High Throughput Screen; 2001 May; 4(3):245-63. PubMed ID: 11375740
[TBL] [Abstract][Full Text] [Related]
2. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
4. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
[TBL] [Abstract][Full Text] [Related]
5. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.
Baranczewski P; Stańczak A; Sundberg K; Svensson R; Wallin A; Jansson J; Garberg P; Postlind H
Pharmacol Rep; 2006; 58(4):453-72. PubMed ID: 16963792
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
7. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries.
Jenkins KM; Angeles R; Quintos MT; Xu R; Kassel DB; Rourick RA
J Pharm Biomed Anal; 2004 Mar; 34(5):989-1004. PubMed ID: 15019033
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism.
Ansede JH; Thakker DR
J Pharm Sci; 2004 Feb; 93(2):239-55. PubMed ID: 14705182
[TBL] [Abstract][Full Text] [Related]
9. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
10. Improvement of "hit-to-lead" optimization by integration of in vitro HTS experimental models for early determination of pharmacokinetic properties.
Kariv I; Rourick RA; Kassel DB; Chung TD
Comb Chem High Throughput Screen; 2002 Sep; 5(6):459-72. PubMed ID: 12470275
[TBL] [Abstract][Full Text] [Related]
11. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
Yan Z; Caldwell GW
Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
[TBL] [Abstract][Full Text] [Related]
12. Early ADME in support of drug discovery: the role of metabolic stability studies.
Thompson TN
Curr Drug Metab; 2000 Nov; 1(3):215-41. PubMed ID: 11465046
[TBL] [Abstract][Full Text] [Related]
13. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
Xu R; Manuel M; Cramlett J; Kassel DB
J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
Kang SY; Yu KN; Joshi P; Lee MY
Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
[TBL] [Abstract][Full Text] [Related]
15. NMR spectroscopy in drug discovery: tools for combinatorial chemistry, natural products, and metabolism research.
Keifer PA
Prog Drug Res; 2000; 55():137-211. PubMed ID: 11127963
[TBL] [Abstract][Full Text] [Related]
16. Drug metabolism and pharmacokinetics in drug discovery.
Roberts SA
Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
[TBL] [Abstract][Full Text] [Related]
17. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
18. Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design.
McConn DJ; Zhao Z
Curr Drug Metab; 2004 Apr; 5(2):141-6. PubMed ID: 15078191
[TBL] [Abstract][Full Text] [Related]
19. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.
Youdim KA; Saunders KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1326-36. PubMed ID: 20207203
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
